在急性髓性白血病中针对CD123的免疫治疗方法
Alexandra Dreyzin1, Noa G Holtzman2,3, Challice L Bonifant4,5
1Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
British journal of haematology
|July 24, 2025
概括
向CD123 (互白素-3受体) 为急性髓性白血病 (AML) 治疗提供了希望. 本综述审查了当前的免疫疗法和新的临床前策略,以提高复发性或耐药性AML的疗效和降低毒性.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 复发性或耐药性急性髓性白血病 (AML) 是一个重大的治疗挑战.
- 目前,针对AML的有限的向免疫疗法可供使用.
- CD123 (互白素-3受体) 是AML爆发的验证标.
研究的目的:
- 审查在AML中针对CD123的免疫疗法的临床结果.
- 讨论导致治疗毒性和有效性有限的因素.
- 突出针对CD123的AML治疗的新型临床前方法.
主要方法:
- 对单克隆抗体,抗体-药物合物,双特异性T细胞参与剂和向CD123的CAR T细胞的临床结果的审查.
- 讨论毒性和疗效限制的潜在原因.
- 确定新兴的临床前CD123向策略.
主要成果:
- 与当前的CD123向疗法观察到的可变抗瘤反应和毒性.
- 诸如差异性抗原表达,AML微环境和T细胞健康等因素会影响疗效.
- 新型临床前方法显示出克服当前局限性的前景.
结论:
- 针对CD123的免疫疗法正在针对AML进行积极的研究.
- 解决毒性和疗效需要了解复杂的生物因素.
- 组合疗法,NK细胞疗法和双特异性T细胞策略代表了有希望的未来方向.
更多相关视频
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.3K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.1K
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K